110 related articles for article (PubMed ID: 2866665)
1. Valproate as psychotropic agent. Interactions and adverse cerebral reactions.
van Sweden B; van Moffaert M
Acta Psychiatr Scand; 1985 Sep; 72(3):315-7. PubMed ID: 2866665
[TBL] [Abstract][Full Text] [Related]
2. Sodium valproate: its use in primary psychiatric disorders.
McElroy SL; Keck PE; Pope HG
J Clin Psychopharmacol; 1987 Feb; 7(1):16-24. PubMed ID: 3102563
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic neurotoxicity; electro-clinical aspects.
van Sweden B
Acta Neurol Scand; 1984 Mar; 69(3):137-46. PubMed ID: 6144229
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-Valproate Adverse Drug Reactions and the Need for a Clozapine Rechallenge Case File.
Kanofsky JD; Woesner ME
Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102977
[No Abstract] [Full Text] [Related]
5. [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
[TBL] [Abstract][Full Text] [Related]
6. Risperidone, a risk factor for valproate-induced encephalopathy?
Rodrigues-Silva N; Venâncio Â; Bouça J
Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937
[TBL] [Abstract][Full Text] [Related]
7. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
8. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
Ravindran A; Silverstone P; Lacroix D; van Schaick E; Vermeulen A; Alexander J
Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
[TBL] [Abstract][Full Text] [Related]
9. DRESS syndrome: Addressing the drug hypersensitivity syndrome on combination of Sodium Valproate and Olanzapine.
Penchilaiya V; Kuppili PP; Preeti K; Bharadwaj B
Asian J Psychiatr; 2017 Aug; 28():175-176. PubMed ID: 28784381
[TBL] [Abstract][Full Text] [Related]
10. Sodium Valproate-Induced Bilateral Pitting Pedal Edema - A Case Report.
Panchal R; Chaudhary D; Anovadiya A
Curr Drug Saf; 2018; 13(2):128-130. PubMed ID: 28782477
[TBL] [Abstract][Full Text] [Related]
11. Catatonia-like events after valproic acid with risperidone and sertraline.
Lauterbach EC
Neuropsychiatry Neuropsychol Behav Neurol; 1998 Jul; 11(3):157-63. PubMed ID: 9742515
[TBL] [Abstract][Full Text] [Related]
12. [Severe vigilance disturbances: a rare complication of sodium valproate treatment (author's transl)].
Cenraud B; Pautrizel B; Berets O; Loiseau P
Rev Electroencephalogr Neurophysiol Clin; 1980; 10(4):376-80. PubMed ID: 6795695
[TBL] [Abstract][Full Text] [Related]
13. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
[TBL] [Abstract][Full Text] [Related]
14. Lithium or Valproate Adjunctive Therapy to Second-generation Antipsychotics and Metabolic Variables in Patients With Schizophrenia or Schizoaffective Disorder.
Vincenzi B; Greene CM; Ulloa M; Parnarouskis L; Jackson JW; Henderson DC
J Psychiatr Pract; 2016 May; 22(3):175-82. PubMed ID: 27123797
[TBL] [Abstract][Full Text] [Related]
15. Valproate-related peripheral oedema: a manageable but probably neglected condition.
Lin ST; Chen CS; Yen CF; Tsei JH; Wang SY
Int J Neuropsychopharmacol; 2009 Aug; 12(7):991-3. PubMed ID: 19490736
[TBL] [Abstract][Full Text] [Related]
16. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
Normann C; Brandt C; Berger M; Walden J
Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
[TBL] [Abstract][Full Text] [Related]
17. Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy.
Chen KC; Yang YK; Chen PS; Yeh TL; Yang MJ
Psychiatry Clin Neurosci; 2003 Aug; 57(4):369-71. PubMed ID: 12839516
[TBL] [Abstract][Full Text] [Related]
18. Valproate in acute mania: is our practice evidence based?
Vasudev K; Mead A; Macritchie K; Young AH
Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
[TBL] [Abstract][Full Text] [Related]
20. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
